Article
Che-1 arrests human colon carcinoma cell proliferation by displacing HDAC1 from the p21WAF1/CIP1 promoter.
Laboratory B.
Journal of Biological Chemistry (impact factor:
4.77).
10/2003;
278(38):36496-504.
DOI:10.1074/jbc.M306694200
pp.36496-504
Source: PubMed
-
Citations (0)
- Cited In (1)
-
Article: Sumoylation of specificity protein 1 augments its degradation by changing the localization and increasing the specificity protein 1 proteolytic process.
[show abstract] [hide abstract]
ABSTRACT: Although specificity protein 1 (Sp1) accumulation has been found in various tumor strains, its mechanism is still not very clear. Herein, we found that modification of Sp1 by SUMO-1 facilitates Sp1 degradation. Our findings revealed that, although the amounts of Sp1 and Sp1 mutant (K16R) [Sp1(K16R)] mRNA in cells were equal, the protein level of Sp1(K16R) was higher than that of wild-type Sp1. We also proved that this sumoylation site was not the residue at which ubiquitination occurred. Invitro and in vivo pull-down assays revealed that more sumoylated Sp1 was localized in the cytoplasm, and the interaction between SUMO-1-Sp1 and the proteasome subunit rpt6 in HeLa cells was enhanced. In addition, although Sp1 accumulated in the tumorous cervical tissue, it was not prone to sumoylation. Finally, by overexpression of HA (hemagglutinin)-SUMO-1-Sp1-myc, HA-Sp1-myc, and HA-Sp1(K16R), we found that modification of Sp1 by SUMO-1 was important for Sp1 proteolysis. In conclusion, modification of Sp1 by SUMO-1 altered its localization and then increased its interaction with rpt6. This interaction increased the efficiency of Sp1 proteolytic processing and ubiquitination and then resulted in Sp1 degradation. Therefore, sumoylation of Sp1 is attenuated during tumorigenesis in order to increase Sp1 stability.Journal of Molecular Biology 08/2008; 380(5):869-85. · 4.00 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed.
The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual
current impact factor.
Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence
agreement may be applicable.
Keywords
accumulating acetylated histone H3
cancer profile arrays
cell cycle
cell proliferation
Che-1 overexpression inhibits proliferation
colon carcinoma cell proliferation
cyclin-dependent kinase inhibitor p21WAF1/Cip1
displacing histone deacetylase
E2F target gene promoters
G1 phase
gene transcription
general HDAC1 competitor
growth arrest
increases cell proliferation
LoVo human colon carcinoma cell lines
p21WAF1/Cip1 gene promoter
Rb growth-suppressing function
Rb-mediated HDAC1 recruitment
relative normal tissues
Sp1 binding sites